The mission of the Bioanalytical Shared Resource is to provide cost effective, state-of-the-art instrumentation to members of the Cancer Center for structural analysis of biological molecules and for qualitative and quantitative assays of chemotherapeutic agents and metabolites in physiologic fluids. The instrumentation facilities consist of a variety of mass spectrometric and high pressure liquid chromatographic systems. Laboratory personnel develop HPLC and MS methods, develop and document standard operating procedures (SOP), maintain QC records on instrument performance, perform routine assays for investigators, carry out instrument maintenance, and train students and fellows in the theoretical and practical aspects of mass spectrometry. Administrative staff monitors the use of the instrument facilities by investigators and prepares reports on Resource utilization for the Center director. The Resource is part of the Vanderbilt University Mass Spectrometry Research Center (MSRC) located in the Medical School. The Research Center consists of a core mass spectrometry service laboratory directed by Dr. Hachey and the research laboratories of Dr. Caprioli. In addition to providing routine analytical and mass spectrometric services via the core facilities, Cancer Center investigators can form collaborations with Dr. Caprioli to solve analytical and structural problems the require non-routine, cutting edge technology. As newer techniques become better understood, they are made available to the user community through the core service laboratory. Thus, the Bioanalytical Shared Resource satisfies the routine analytical needs of Cancer Center investigators, and also makes available new analytical capabilities for research problems demanding more innovative solutions that are beyond the scope of a service laboratory.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA068485-04
Application #
6232780
Study Section
Subcommittee G - Education (NCI)
Project Start
1995-09-05
Project End
2004-08-31
Budget Start
Budget End
Support Year
4
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Iams, Wade T; Yu, Hui; Shyr, Yu et al. (2018) First-line Chemotherapy Responsiveness and Patterns of Metastatic Spread Identify Clinical Syndromes Present Within Advanced KRAS Mutant Non-Small-cell Lung Cancer With Different Prognostic Significance. Clin Lung Cancer 19:531-543
Diggins, Kirsten E; Gandelman, Jocelyn S; Roe, Caroline E et al. (2018) Generating Quantitative Cell Identity Labels with Marker Enrichment Modeling (MEM). Curr Protoc Cytom 83:10.21.1-10.21.28
Warner, Jeremy L; Prasad, Ishaan; Bennett, Makiah et al. (2018) SMART Cancer Navigator: A Framework for Implementing ASCO Workshop Recommendations to Enable Precision Cancer Medicine. JCO Precis Oncol 2018:
Brown, Judy J; Short, Sarah P; Stencel-Baerenwald, Jennifer et al. (2018) Reovirus-Induced Apoptosis in the Intestine Limits Establishment of Enteric Infection. J Virol 92:
Engevik, Amy C; Kaji, Izumi; Engevik, Melinda A et al. (2018) Loss of MYO5B Leads to Reductions in Na+ Absorption With Maintenance of CFTR-Dependent Cl- Secretion in Enterocytes. Gastroenterology 155:1883-1897.e10
Earl, David C; Ferrell Jr, P Brent; Leelatian, Nalin et al. (2018) Discovery of human cell selective effector molecules using single cell multiplexed activity metabolomics. Nat Commun 9:39
Hormuth 2nd, David A; Eldridge, Stephanie L; Weis, Jared A et al. (2018) Mechanically Coupled Reaction-Diffusion Model to Predict Glioma Growth: Methodological Details. Methods Mol Biol 1711:225-241
Lockhart, Jacob N; Spoonmore, Thomas J; McCurdy, Michael W et al. (2018) Poly(glycidol) Coating on Ultrahigh Molecular Weight Polyethylene for Reduced Biofilm Growth. ACS Appl Mater Interfaces 10:4050-4056
Rogers, Meredith C; Lamens, Kristina D; Shafagati, Nazly et al. (2018) CD4+ Regulatory T Cells Exert Differential Functions during Early and Late Stages of the Immune Response to Respiratory Viruses. J Immunol 201:1253-1266
Takata, Yumie; Xiang, Yong-Bing; Burk, Raymond F et al. (2018) Plasma selenoprotein P concentration and lung cancer risk: results from a case-control study nested within the Shanghai Men's Health Study. Carcinogenesis 39:1352-1358

Showing the most recent 10 out of 2462 publications